TickerFacts.

Propanc Biopharma, Inc. (PPCB): Cash & Equivalents

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2022-06-30, while the company's latest annual report covers the year ended 2026-06-30. Its later filings do not report this line under the concept TickerFacts maps.

$4.1K
As of 2022-06-30
+36.7%
10-year compound annual growth
$87.8K2011-06-30: $1322012-06-30: $1792013-06-30: $02014-06-30: $87.8K2020-06-30: $67.0K2021-06-30: $2.3K2022-06-30: $4.1K$4.1K
2011-06-30 Cash & Equivalents (USD) 2022-06-30
Period endedCash & EquivalentsChange YoYSource filing
2022-06-30$4.1K+80.4%2022-09-28, Balance as of period end
2021-06-30$2.3K-96.6%2022-09-28, Balance as of period end
2020-06-30$67.0Kn/a2021-09-28, Balance as of period end
No annual figure between 2014-06-30 and 2020-06-30.
2014-06-30$87.8Kn/a2014-10-14, Balance as of period end
2013-06-30$0-100.0%2014-10-14, Balance as of period end
2012-06-30$179+35.6%2013-10-15, Balance as of period end
2011-06-30$132n/a2013-10-15, Balance as of period end